These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1899479)

  • 1. A single site mutation in a truncated Fos protein allows it to interact with the TRE in vitro.
    Nicklin MJ; Casari G
    Oncogene; 1991 Jan; 6(1):173-9. PubMed ID: 1899479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding site.
    Neuberg M; Adamkiewicz J; Hunter JB; Müller R
    Nature; 1989 Sep; 341(6239):243-5. PubMed ID: 2506451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of functional domains in Fos and Jun proteins using epitope-specific antibodies.
    Adamkiewicz J; Brüller HJ; Gausepohl H; Frank R; Müller R
    Oncogene; 1990 Apr; 5(4):525-33. PubMed ID: 1691478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encounters with Fos and Jun on the road to AP-1.
    Abate C; Curran T
    Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
    Busch SJ; Sassone-Corsi P
    Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis of the DNA contact site in Fos protein: compatibility with the scissors grip model and requirement for transformation.
    Neuberg M; Schuermann M; Müller R
    Oncogene; 1991 Aug; 6(8):1325-33. PubMed ID: 1909428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex.
    Neuberg M; Schuermann M; Hunter JB; Müller R
    Nature; 1989 Apr; 338(6216):589-90. PubMed ID: 2494459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. fos and jun interaction: the role of the leucine zipper.
    Ransone LJ; Visvader J; Lamph WW; Sassone-Corsi P; Verma IM
    Int J Cancer Suppl; 1989; 4():10-21. PubMed ID: 2509385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
    Kouzarides T; Ziff E
    Nature; 1989 Aug; 340(6234):568-71. PubMed ID: 2505081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
    Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the leucine zipper in the fos-jun interaction.
    Kouzarides T; Ziff E
    Nature; 1988 Dec; 336(6200):646-51. PubMed ID: 2974122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
    Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
    Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse vimentin: structural relationship to fos, jun, CREB and tpr.
    Capetanaki Y; Kuisk I; Rothblum K; Starnes S
    Oncogene; 1990 May; 5(5):645-55. PubMed ID: 2140597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1.
    Macgregor PF; Abate C; Curran T
    Oncogene; 1990 Apr; 5(4):451-8. PubMed ID: 2139203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.